'Toxic' oestrogen by-product linked with fatal lung condition

August 6, 2012

(Medical Xpress) -- The breakdown of oestrogen could play an important role in the onset of a rare but devastating condition of high blood pressure in the lungs.

In a study funded by the British Heart Foundation (BHF) and published in journal Circulation, scientists from the University of Glasgow showed that high levels of an enzyme in the lungs called CYP1B1 – which breaks down oestrogen into harmful smaller molecules – could play a role in the development of pulmonary arterial hypertension.

Around 3,000 people in the UK have pulmonary arterial hypertension, when overactive cell growth in blood vessel walls reduces the space for blood flow in the lungs. Often affecting younger, pre-menopausal women, symptoms include breathlessness and chest pain. The signs worsen as lung blood pressure increases, and the disorder is often fatal. More than one in ten patients die within the first year of diagnosis.

Although there are treatments available, they are often not effective.

This new study shows a link between high levels of a harmful molecule produced from the breakdown of oestrogen by CYP1B1 and the development of pulmonary arterial hypertension. The findings could help lead to new treatments to tackle the disease.

The researchers showed that CYP1B1 levels were elevated in the lungs of mice with pulmonary arterial hypertension, and that lowering CYP1B1 levels reduced the severity of the disease. A ‘toxic’ by-product of oestrogen – called 16α-hydroxyestrone – was found in elevated amounts in the urine of mice that did develop the condition.

Importantly, the researchers also examined a small number of lung samples from human patients with pulmonary hypertension – all of whom had elevated levels of CYP1B1. This means that targeting the enzyme with a specific drug in the future might make a difference for patients.

Professor Mandy MacLean, Professor of Pulmonary Pharmacology at the University of Glasgow’s Institute of Cardiovascular and Medical Sciences, who leads a BHF programme grant, said: “Pulmonary arterial hypertension is a really debilitating disease, often fatal, that we need to do more to understand.

“We found that its onset seems to have a lot to do with raised levels of toxic molecules in the lungs, produced from the breakdown of oestrogen by a regulatory protein that’s gone out of control.

“We think it’s an important discovery because drugs that target this protein – called CYP1B1 – already exist, so our discovery provides a real rationale to go on to test these drugs in human patients.”

Dr Shannon Amoils, Research Advisor at the BHF, which co-funded the research, said: “ is more common in women, which has led to the suggestion that the higher oestrogen levels found in women might be linked to higher risk. Up till now, though, studies in animal models haven’t come up with a clear answer.

“This interesting study in mice, which also looked at human samples, shows that abnormal oestrogen breakdown in the lungs may be an important factor. But many questions about this condition are still unanswered, and the next stage is to move on to examine this association more closely in patients.”

Explore further: Potential new approach to treatment of chronic lung diseases

Related Stories

Potential new approach to treatment of chronic lung diseases

March 26, 2012
(Medical Xpress) -- Scientists at UCD have identified a potential new treatment for life-threatening complications associated with chronic obstructive lung diseases like emphysema and chronic bronchitis. Chronic obstructive ...

Researchers move closer to a cure for a deadly cardiovascular disease

June 24, 2011
(Medical Xpress) -- A multidisciplinary research team in the Faculty of Medicine & Dentistry at the University of Alberta has taken a big step towards understanding the cause and potential cure for a deadly cardiovascular ...

Recommended for you

Hibernating ground squirrels provide clues to new stroke treatments

November 17, 2017
In the fight against brain damage caused by stroke, researchers have turned to an unlikely source of inspiration: hibernating ground squirrels.

Age and gut bacteria contribute to multiple sclerosis disease progression

November 17, 2017
Researchers at Rutgers Robert Wood Johnson Medical School published a study suggesting that gut bacteria at young age can contribute to multiple sclerosis (MS) disease onset and progression.

Molecular guardian defends cells, organs against excess cholesterol

November 16, 2017
A team of researchers at the Harvard T. H. Chan School of Public Health has illuminated a critical player in cholesterol metabolism that acts as a molecular guardian in cells to help maintain cholesterol levels within a safe, ...

Prototype ear plug sensor could improve monitoring of vital signs

November 16, 2017
Scientists have developed a sensor that fits in the ear, with the aim of monitoring the heart, brain and lungs functions for health and fitness.

Ancient enzyme could boost power of liquid biopsies to detect and profile cancers

November 16, 2017
Scientists are developing a set of medical tests called liquid biopsies that can rapidly detect the presence of cancers, infectious diseases and other conditions from only a small blood sample. Researchers at The University ...

FDA to crack down on risky stem cell offerings

November 16, 2017
U.S. health authorities announced plans Thursday to crack down on doctors pushing stem cell procedures that pose the gravest risks to patients amid an effort to police a burgeoning medical field that previously has received ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.